Evaluation of immune responses in adults after vaccination or infection
Official title: VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Run by National Institutes of Health Clinical Center (CC) · NCT01132859 · Data updated 2026-11-12
This study is testing how well the immune system responds in adults after they get vaccinated or recover from an infection to help improve future vaccines.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | May 18, 2010 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT01132859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18 years and older who are willing to donate specimens for research purposes.
✕Probably not a fit
Patients with medical conditions that impair their ability to provide informed consent or those with bleeding disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate immune responses in adults aged 18 and older by collecting blood and tissue samples from individuals who have recently been vaccinated or recovered from infections. Participants will undergo clinical evaluations and provide various specimens, including blood and mucosal samples, to help researchers understand the immune correlates of protection. The data collected will enhance knowledge about immune responses and assist in the development of vaccines against infectious diseases. Participation is voluntary, and all procedures are optional.
Why it matters
Potential benefit: If successful, this study could lead to improved vaccine development and better understanding of immune responses to infections.
How similar studies have gone: Other studies have shown success in evaluating immune responses through similar specimen collection methods, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: 1. 18 years of age or older. 2. Able to provide proof of identity to the satisfaction of the study clinician completing the enrollment process. 3. Able and willing to complete the informed consent process. 4. Willing to donate specimens for storage to be used for research. EXCLUSION CRITERIA: 1. Any medical, psychiatric, occupational condition or other condition that, in the judgment of the investigator, is a contraindication to protocol participation or impairs a participant s ability to give informed consent. 2. Bleeding disorder diagnosed by a doctor (e.g., factor deficiency, coagulopathy, or platelet disorder requiring special precautions), use of anticoagulant medications for an ongoing medical condition, significant bruising or bleeding difficulties with intramuscular injections or blood draws. \[Note: Participants taking anticoagulants, such as aspirin, prophylactically may be considered on a case to case basis.\]
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Lesia K Dropulic, M.D. — National Institute of Allergy and Infectious Diseases (NIAID)
- Study coordinator: OPS Team, VRC
- Email: vrcops@nih.gov
- Phone: Not Listed
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pneumatic Tube System vs. Manual Transport for Blood Samples in ED
This study tests whether using a pneumatic tube system versus manual transport affects how often blood samples from the emergency department show hemolysis.
-
Neutralizing power of blood and nasal antibodies
This project will test how strong blood and nasal antibodies remain over time in adults getting COVID-19 or monkeypox vaccines or antibody treatments.
-
Evaluating immune responses in South African children with respiratory infections
This study is trying to understand how children's immune systems respond to respiratory infections, like COVID-19, to see how these illnesses affect their health and quality of life.
-
Controlled exposure to a viral mimic for studying lung immune responses
This study tests how people with asthma and healthy volunteers respond to a safe viral mimic to help understand and improve treatments for lung inflammation and asthma.
-
Hand puppets versus image viewing and coloring books to reduce pain and fear during children's blood draws
This will test whether using a hand puppet or letting 3- to 6-year-old children look at and color pictures helps them feel less pain and fear during a blood draw.
-
Evaluating a new blood self-collection device for diagnostic tests
This study is testing a new device that lets people collect their own blood samples at home to see if it works as well as traditional blood draws done in a clinic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.